• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SWIGH评分:一种用于单克隆淋巴细胞增殖性疾病的计算检测重排免疫球蛋白重链的转化轻量级方法。

SWIGH-SCORE: A translational light-weight approach in computational detection of rearranged immunoglobulin heavy chain to be used in monoclonal lymphoproliferative disorders.

作者信息

Hansen Marcus Høy, Maagaard Markus, Cédile Oriane, Nyvold Charlotte Guldborg

机构信息

Haematology-Pathology Research Laboratory, Research Unit of Haematology, Department of Hematology, and Research Unit of Pathology, Department of Pathology, University of Southern Denmark and Odense University Hospital, Odense, Denmark.

OPEN, Odense Patient data Explorative Network, Haematology-Pathology Research Laboratory, Odense University Hospital, Odense, Denmark.

出版信息

MethodsX. 2024 May 10;12:102741. doi: 10.1016/j.mex.2024.102741. eCollection 2024 Jun.

DOI:10.1016/j.mex.2024.102741
PMID:38846434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11154698/
Abstract

We present a lightweight tool for clonotyping and measurable residual disease (MRD) assessment in monoclonal lymphoproliferative disorders. It is a translational method that enables computational detection of rearranged immunoglobulin heavy chain gene sequences.•The clonotyping tool emphasizes parallelization and applicability across sequencing platforms.•The algorithm is based on an adaptation of the Smith-Waterman algorithm for local alignment of reads generated by 2nd and 3rd generation of sequencers.For method validation, we demonstrate the targeted sequences of immunoglobulin heavy chain genes from diagnostic bone marrow using serial dilutions of CD138+ plasma cells from a patient with multiple myeloma. Sequencing libraries from diagnostic samples were prepared for the three sequencing platforms, Ion S5 (Thermo Fisher Scientific), MiSeq (Illumina), and MinION (Oxford Nanopore), using the LymphoTrack assay. Basic quality filtering was performed, and a Smith-Waterman-based algorithm was developed in shell and C for clonotyping and MRD assessment using FASTQ data files. Performance is demonstrated across the three different sequencing platforms.

摘要

我们展示了一种用于单克隆淋巴细胞增殖性疾病克隆分型和可测量残留疾病(MRD)评估的轻量级工具。这是一种转化方法,能够通过计算检测重排的免疫球蛋白重链基因序列。•该克隆分型工具强调跨测序平台的并行化和适用性。•该算法基于对Smith-Waterman算法的改编,用于对第二代和第三代测序仪生成的 reads 进行局部比对。为了进行方法验证,我们使用来自一名多发性骨髓瘤患者的CD138+浆细胞的系列稀释液,展示了诊断性骨髓中免疫球蛋白重链基因的靶向序列。使用LymphoTrack检测法为三个测序平台Ion S5(赛默飞世尔科技公司)、MiSeq(Illumina)和MinION(牛津纳米孔公司)制备了诊断样本的测序文库。进行了基本的质量过滤,并在 shell 和 C 语言中开发了一种基于 Smith-Waterman 的算法,用于使用FASTQ数据文件进行克隆分型和MRD评估。在三种不同的测序平台上展示了其性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/11154698/fc720c3f7df6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/11154698/860f9ac72d7c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/11154698/fc720c3f7df6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/11154698/860f9ac72d7c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/11154698/fc720c3f7df6/gr1.jpg

相似文献

1
SWIGH-SCORE: A translational light-weight approach in computational detection of rearranged immunoglobulin heavy chain to be used in monoclonal lymphoproliferative disorders.SWIGH评分:一种用于单克隆淋巴细胞增殖性疾病的计算检测重排免疫球蛋白重链的转化轻量级方法。
MethodsX. 2024 May 10;12:102741. doi: 10.1016/j.mex.2024.102741. eCollection 2024 Jun.
2
The potential of 3rd-generation nanopore sequencing for B-cell clonotyping in lymphoproliferative disorders.第三代纳米孔测序在淋巴增殖性疾病中进行B细胞克隆分型的潜力。
EJHaem. 2023 Nov 23;5(1):290-293. doi: 10.1002/jha2.815. eCollection 2024 Feb.
3
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.对 clonoSEQ 检测方法在急性淋巴细胞白血病、慢性淋巴细胞白血病和多发性骨髓瘤中建立可测量(最小)残留病的分析评估。
BMC Cancer. 2020 Jun 30;20(1):612. doi: 10.1186/s12885-020-07077-9.
4
Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.通过下一代测序检测免疫球蛋白重链基因克隆性用于B淋巴细胞白血病微小残留病监测
Ann Lab Med. 2017 Jul;37(4):331-335. doi: 10.3343/alm.2017.37.4.331.
5
LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients.LymphoTrack在检测急性淋巴细胞白血病(ALL)患者的克隆重排方面与PCR基因扫描和桑格测序同样敏感。
Diagnostics (Basel). 2022 Jun 4;12(6):1389. doi: 10.3390/diagnostics12061389.
6
[Assessment of minimal residual disease in adult patients with B-lineage acute lymphoblastic leukemia using rearranged immunoglobulin loci detection].[利用重排免疫球蛋白基因座检测评估成人B系急性淋巴细胞白血病患者的微小残留病]
Zhonghua Xue Ye Xue Za Zhi. 2010 Jul;31(7):433-7.
7
MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.以Ig基因重排和染色体易位为实时定量PCR靶点检测B细胞非霍奇金淋巴瘤中的微小残留病
Methods Mol Biol. 2019;1956:199-228. doi: 10.1007/978-1-4939-9151-8_9.
8
Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.评估二代测序与二代流式细胞术用于中国多发性骨髓瘤患者微小残留病检测的效果
Discov Oncol. 2024 Mar 19;15(1):78. doi: 10.1007/s12672-024-00938-w.
9
Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancers.通过Ion Torrent S5新一代测序技术进行IGH和TCR克隆性检测在B细胞和T细胞癌症诊断及疾病监测中的验证与解读
Pract Lab Med. 2020 Nov 25;22:e00191. doi: 10.1016/j.plabm.2020.e00191. eCollection 2020 Nov.
10
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data.HashClone:一种从深度测序数据中量化B细胞淋巴瘤微小残留病的新工具。
BMC Bioinformatics. 2017 Nov 23;18(1):516. doi: 10.1186/s12859-017-1923-2.

本文引用的文献

1
The potential of 3rd-generation nanopore sequencing for B-cell clonotyping in lymphoproliferative disorders.第三代纳米孔测序在淋巴增殖性疾病中进行B细胞克隆分型的潜力。
EJHaem. 2023 Nov 23;5(1):290-293. doi: 10.1002/jha2.815. eCollection 2024 Feb.
2
Toward Cytogenomics: Technical Assessment of Long-Read Nanopore Whole-Genome Sequencing for Detecting Large Chromosomal Alterations in Mantle Cell Lymphoma.迈向细胞基因组学:长读长纳米孔全基因组测序技术在套细胞淋巴瘤中检测大的染色体改变的技术评估。
J Mol Diagn. 2023 Nov;25(11):796-805. doi: 10.1016/j.jmoldx.2023.08.004. Epub 2023 Sep 7.
3
Cell-free DNA for detection of clonal B cells in diffuse large B cell lymphoma by sequencing.
通过测序检测弥漫性大 B 细胞淋巴瘤中克隆性 B 细胞的游离 DNA。
Int J Lab Hematol. 2023 Oct;45(5):735-742. doi: 10.1111/ijlh.14116. Epub 2023 Jun 22.
4
Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma.套细胞淋巴瘤中可测量残留病灶(MRD)评估的效用。
Curr Treat Options Oncol. 2023 Aug;24(8):929-947. doi: 10.1007/s11864-023-01102-2. Epub 2023 May 30.
5
Benchmarking of Nanopore R10.4 and R9.4.1 flow cells in single-cell whole-genome amplification and whole-genome shotgun sequencing.纳米孔R10.4和R9.4.1流动槽在单细胞全基因组扩增和全基因组鸟枪法测序中的基准测试
Comput Struct Biotechnol J. 2023 Mar 24;21:2352-2364. doi: 10.1016/j.csbj.2023.03.038. eCollection 2023.
6
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing.使用超深度测序技术检测低水平残留骨髓瘤免疫球蛋白的可重复性。
Exp Hematol. 2023 Mar-Apr;119-120:14-20. doi: 10.1016/j.exphem.2023.01.002. Epub 2023 Jan 25.
7
Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia.游离DNA中克隆性IGH重排的纳米孔测序作为急性淋巴细胞白血病的生物标志物
Front Oncol. 2022 Dec 14;12:958673. doi: 10.3389/fonc.2022.958673. eCollection 2022.
8
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.国际专家组关于毛细胞白血病可测量残留病的共识意见。
Blood Cancer J. 2022 Dec 13;12(12):165. doi: 10.1038/s41408-022-00760-z.
9
Exploration of residual disease in stem cell products from mantle cell lymphoma using next-generation sequencing.利用二代测序技术探索套细胞淋巴瘤干细胞产品中的残留病灶。
Leuk Res Rep. 2022 Aug 9;18:100341. doi: 10.1016/j.lrr.2022.100341. eCollection 2022.
10
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.循环肿瘤 DNA 在 B 细胞淋巴瘤中的应用:技术进展、临床应用及转化研究展望。
Leukemia. 2022 Sep;36(9):2151-2164. doi: 10.1038/s41375-022-01618-w. Epub 2022 Jun 14.